• About
  • Licensing
  • Podcasting
  • Contact

AudioMedica.com

  • Public Health
  • Oncology
  • Cardiovascular
  • General Medicine

Tagged: hematologic

  • Audio Journal of Oncology in Advance – March 15th, 2008
    • in Oncology
    • — 16 Mar, 2008

    Audio Journal of Oncology in Advance – March 15th, 2008

    Volume 16 Number 6 (March 15th, 2008) reporting from:
    4th European Congress on Hematologic Malignancies (February 22-24, 2008, Paris)
    American Society of Hematology Annual Meeting (December 8-11, 2007 Atlanta)
    Chemotherapy Foundation Symposium, November 7-10, 2007, New York

    David Maloney
    David Maloney

    Nonmyeloablative

    …
    Read more
    Audio Journal of Oncology in Advance – March 1st, 2008
    • in Oncology
    • — 4 Mar, 2008

    Audio Journal of Oncology in Advance – March 1st, 2008

    Volume 16 Number 5 (March 1st, 2008) reporting from:
    4th European Congress on Hematologic Malignancies (February 22-24, 2008, Paris)
    Gastrointestinal Cancers Symposium (January 25-27, 2008, Orlando)
    American Society of Hematology Annual Meeting (December 8-11, 2007 Atlanta)

    Richard Stone
    Richard Stone
    George Canellos
    George Canellos
    …
    Read more
  • Radio-Labelled Antibodies: Big Benefits in Follicular Lymphoma?
    • in General Medicine
    • — 27 Feb, 2008

    Radio-Labelled Antibodies: Big Benefits in Follicular Lymphoma?

    Timothy Illidge
    Timothy Illidge

    Reporting From: 4th European Congress on Hematologic Malignancies, Paris 22-24 February, 2008
    TIMOTHY ILLIDGE, Christie Hospital, Manchester
    Radioconjugated antibodies are showing great promise for treating follicular lymphoma which has failed chemotherapy combined with rituximab. That’s according to Tim
    …
    Read more
    Chronic Lymphocytic Leukemia After Fludarabine Failure
    • in News · Oncology
    • — 26 Feb, 2008

    Chronic Lymphocytic Leukemia After Fludarabine Failure

    John Gribben
    John Gribben

    Reporting From: 4th European Congress on Hematologic Malignancies, Paris 22-24 February, 2008
    JOHN GRIBBEN, Bartholemews Hospital, London
    New promise for treating chronic lymphocytic leukemia is arising from combining antibody therapies rituximab and alemtuzumab with new drugs such as
    …
    Read more
    • in Oncology
    • — 10 Dec, 2007

    Live Report from ASH:
    Oblimersen Extends Survival in Chronic Lymphocytic Leukemia

    Susan O’Brien
    Susan O’Brien

    SUSAN O’BRIEN, MD Anderson Cancer Center, Houston
    For patients with relapsed or refractory CLL, oblimersen extends survival when added to standard fludarabine/cyclophosphamide chemotherapy. Susan O’Brien presented data from this phase III trial to the American Society of Hematology
    …
    Read more
    New Drug AMG 531 Effective in Splenectomized Patients with Chronic Immune Thrombocytopenic Purpura
    • in General Medicine
    • — 9 Dec, 2007

    New Drug AMG 531 Effective in Splenectomized Patients with Chronic Immune Thrombocytopenic Purpura

    Terry Gernsheimer
    Terry Gernsheimer

    TERRY GERNSHEIMER, University of Washington Medical Center, Seattle
    An investigational drug AMG 531 has increased and sustained platelet counts in splenectomized patients with chronic immune thrombocytopenic purpura or ITP. This was in a placebo controlled phase III trial
    …
    Read more
  • No Use Of Hydroxyurea In Country With Most Sickle Cell Anemia
    • in Public Health
    • — 9 Dec, 2007

    No Use Of Hydroxyurea In Country With Most Sickle Cell Anemia

    Zakari Aliyu
    Zakari Aliyu

    REFERENCE: American Society of Hematology Annual Meeting, December 8-11 2007, Atlanta
    ZAKARI ALIYU, Howard University, Washington DC
    Nigeria has the highest incidence of sickle cell anemia in the world, with over 150,000 children being born each year with
    …
    Read more
    Large Risk Reduction For Rivaroxaban In Blood Clot Prevention
    • in General Medicine
    • — 9 Dec, 2007

    Large Risk Reduction For Rivaroxaban In Blood Clot Prevention

    Bengt Eriksson
    Bengt Eriksson

    REFERENCE: Abstract 6, American Society of Hematology Annual Meeting, December 8-11 2007, Atlanta
    BENGT ERIKSSON, Gothenburg University
    In a large phase III trial of patients having a hip replacement, the oral anticoagulant rivaroxaban has shown significant benefit when
    …
    Read more
  • ASCO Audio Journal of Oncology – June 6th 2006, from the ASCO Annual Meeting in Atlanta, June 2-6
    • in AJO · ASCO · Oncology
    • — 5 Jun, 2006

    ASCO Audio Journal of Oncology – June 6th 2006, from the ASCO Annual Meeting in Atlanta, June 2-6

    Robert Mayer
    Robert Mayer
    Thierry Facon
    Thierry Facon
     Ibrahim Yakoub-Agha
    Ibrahim Yakoub-Agha
    Peter Paschka
    Peter Paschka

    Robert Mayer of the Dana-Farber Cancer Institute in Boston joins Derek Thorne to discuss the major hematologic malignancy news reported at the 2006 ASCO meeting.

    – Older patients with multiple myeloma can

    …
    Read more
    Audio Journal of Hematologic Malignancy Special Edition 2005
    • in AJO
    • — 8 Dec, 2005

    Audio Journal of Hematologic Malignancy Special Edition 2005

    Audio Journal of Hematologic Malignancy Special Edition 2005

    Reporting from:
    – Annual Meeting of the American Society of Hematology, December 4-7, 2004, San Diego
    – Lymphoma: The Next Questions, April 8-9, 2005, Fort Lauderdale
    – Journal of Clinical Oncology

    In this edition:

    The newer the better, so they …

    Read more
  • Sign up for AudioMedica.com news

    * = required field
    Speciality




  • Home
  • Tagged: hematologic

© COPYRIGHT 2020 AUDIOMEDICA.COM.